(Q45010454)

8 December 2017

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses (English)

1 reference

8 December 2017

1 reference

1

1 reference

8 December 2017

Andreas Palmborg

2

1 reference

8 December 2017

Gawa Bidla

3

1 reference

8 December 2017

Mike Whelan

4

1 reference

8 December 2017

Hardev Pandha

5

1 reference

8 December 2017

Pavel Pisa

6

1 reference

8 December 2017

1 January 2004

1 reference

8 December 2017

1 reference

8 December 2017

21

1 reference

8 December 2017

2

1 reference

8 December 2017

155-165

1 reference

https://scigraph.springernature.com/pub.10.1385/mo:21:2:155

8 December 2017

0 references

cites work

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

12 December 2020

Dendritic cells as a tool to induce anergic and regulatory T cells

1 reference

12 December 2020

MHC antigens and tumor escape from immune surveillance

1 reference

12 December 2020

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine

1 reference

12 December 2020

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

1 reference

12 December 2020

Autologous and allogenic hybrid cell vaccine in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

12 December 2020

Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines

1 reference

12 December 2020

Identification of human cancers deficient in antigen processing

1 reference

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

12 December 2020

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

12 December 2020

Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis

1 reference

12 December 2020

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

1 reference

12 December 2020

Migration patterns of dendritic cells in the rat: comparison of the effects of gamma and UV-B irradiation on the migration of dendritic cells and Lymphocytes

1 reference

12 December 2020

Ex vivo generation of human anti-melanoma autologous cytolytic T cells by dentritic cell/melanoma cell hybridomas

1 reference

12 December 2020

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

1 reference

12 December 2020

Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.

1 reference

12 December 2020

The polyepitope approach to DNA vaccination

1 reference

12 December 2020

Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells

1 reference

12 December 2020

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

1 reference

12 December 2020

A rapid, novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dentritomas

1 reference

12 December 2020

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination

1 reference

12 December 2020

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

12 December 2020

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

1 reference

12 December 2020

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

12 December 2020

Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.

1 reference

12 December 2020

Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens

1 reference

12 December 2020

Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells

1 reference

12 December 2020

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:21:2:155

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference